{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:26:59Z","timestamp":1786505219257,"version":"build-2736575974"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2024\/R\/1446"],"award-info":[{"award-number":["PSAU\/2024\/R\/1446"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156588","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:07:20Z","timestamp":1781050040000},"page":"156588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting ferroptosis with resveratrol: Advances in mechanistic understanding and cancer therapy applications"],"prefix":"10.1016","volume":"286","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4149-3978","authenticated-orcid":false,"given":"Fahad","family":"Alsaikhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.15537\/1658-3175.8333","article-title":"Global cancer burden growing, amidst mounting need for services","volume":"45","year":"2024","journal-title":"Saudi Med. J."},{"issue":"16_","key":"10.1016\/j.prp.2026.156588_bib2","article-title":"Aging and global cancer burden: A population-based comparative situation analysis and predictions from GLOBOCAN and UN databases","volume":"43","author":"Patel","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156588_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103851","article-title":"Inequality in breast cancer: Global statistics from 2022 to 2050","volume":"79","author":"Liao","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.prp.2026.156588_bib4","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fonc.2024.1466159","article-title":"Global, regional, and national trends in colorectal cancer burden from 1990 to 2021 and projections to 2040","volume":"14","author":"Zhang","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12885-025-13471-y","article-title":"The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021","volume":"25","author":"Yu","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2026.156588_bib6","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fmed.2025.1533544","article-title":"The burden and trends of gastric cancer from 1990 to 2021 in China and globally: a cross-sectional study","volume":"12","author":"Yin","year":"2025","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12837","article-title":"Resveratrol in the treatment of pancreatic cancer","volume":"1348","author":"Xu","year":"2015","journal-title":"Ann. New. Y. Acad. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib8","article-title":"Anticancer drug discovery from natural compounds targeting PI3K\/AKT\/mTOR signaling pathway","author":"Figueiredo da Silva","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/01635581.2021.1931364","article-title":"Natural lignans honokiol and magnolol as potential anticarcinogenic and anticancer agents. A comprehensive mechanistic review","volume":"74","author":"Mottaghi","year":"2022","journal-title":"Nutr. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10286020.2023.2249825","article-title":"A review on marine source as anticancer agents","volume":"26","author":"Rai","year":"2024","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib11","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.3390\/ijms25084505","article-title":"Can compounds of natural origin be important in chemoprevention? Anticancer properties of quercetin, resveratrol, and curcumin\u2014A comprehensive review","volume":"25","author":"Cecerska-Hery\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.12775\/JEHS.2024.51.009","article-title":"Resveratrol-its properties, occurrence and health benefits","volume":"51","author":"Jab\u0142o\u0144ska","year":"2024","journal-title":"J. Educ. Health Sport."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/foods9030340","article-title":"Health benefits and molecular mechanisms of resveratrol: a narrative review","volume":"9","author":"Meng","year":"2020","journal-title":"Foods"},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/fft2.375","article-title":"Certainty and uncertainty in the biological activities of resveratrol","volume":"5","author":"Drago","year":"2024","journal-title":"Food Front."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/acs.chemrestox.4c00436","article-title":"A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway","volume":"38","author":"Soonthonsrima","year":"2025","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/antiox14060654","article-title":"Emerging Trends in Green Extraction Techniques, Chemical Modifications, and Drug Delivery Systems for Resveratrol","volume":"14","author":"Trombino","year":"2025","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/ma18020457","article-title":"Films Based on Chitosan\/Konjac Glucomannan Blend Containing Resveratrol for Potential Skin Application","volume":"18","author":"Kulka-Kami\u0144ska","year":"2025","journal-title":"Materials"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/molecules30040958","article-title":"Recent advances in resveratrol derivatives: Structural modifications and biological activities","volume":"30","author":"Liu","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2026.156588_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2020.00239","article-title":"Ferroptosis and Its Potential Role in Human Diseases","volume":"11","author":"Han","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156588_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.879317","article-title":"Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges","volume":"13","author":"Nie","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156588_bib21","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fphar.2024.1473939","article-title":"Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics","volume":"15","author":"Peng","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156588_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.hermed.2022.100550","article-title":"Resveratrol\u2019 biotechnological applications: Enlightening its antimicrobial and antioxidant properties","volume":"32","author":"Sharifi-Rad","year":"2022","journal-title":"J. Herbal. Med."},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/jf9504576","article-title":"Resveratrol: isomeric molar absorptivities and stability","volume":"44","author":"Trela","year":"1996","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib24","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/fsn3.3933","article-title":"Exploring the multimodal health-promoting properties of resveratrol: A comprehensive review","volume":"12","author":"Faisal","year":"2024","journal-title":"Food Sci. & Nutr."},{"issue":"20","key":"10.1016\/j.prp.2026.156588_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204486","article-title":"The Pharmacological Properties of Red Grape Polyphenol Resveratrol: Clinical Trials and Obstacles in Drug Development","volume":"15","author":"Farhan","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2026.156588_bib26","article-title":"Resveratrol: A comprehensive review of its multifaceted health benefits, mechanisms of action, and potential therapeutic applications in chronic disease","volume":"3","author":"Vikal","year":"2024","journal-title":"Pharmacol. Res. -Nat. Prod."},{"issue":"17","key":"10.1016\/j.prp.2026.156588_bib27","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.1021\/cr500689b","article-title":"Chemistry and biology of resveratrol-derived natural products","volume":"115","author":"Keylor","year":"2015","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib28","article-title":"Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans","volume":"2015","author":"Gambini","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prp.2026.156588_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1408651","article-title":"Multidimensional biological activities of resveratrol and its prospects and challenges in the health field","volume":"11","author":"Yu","year":"2024","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26010229","article-title":"Anti-Inflammatory Action and Mechanisms of Resveratrol","volume":"26","author":"Meng","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib31","article-title":"An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol","volume":"2015","author":"Malhotra","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prp.2026.156588_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1368949","article-title":"Resveratrol and vascular health: Evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota","volume":"15","author":"Godos","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156588_bib33","first-page":"602","article-title":"Recent studies on resveratrol and its biological and pharmacological activity","volume":"16","author":"Kim","year":"2017","journal-title":"Excli J."},{"key":"10.1016\/j.prp.2026.156588_bib34","article-title":"Efficacy of resveratrol supplementation on glucose and lipid metabolism: A meta-analysis and systematic review","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.prp.2026.156588_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2015.01.002","article-title":"Resveratrol supplementation: Where are we now and where should we go?","volume":"21","author":"Novelle","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/jfbc\/8210896","article-title":"Green Production Pathways, Instability, and Stability of Resveratrol: A Systematic Review","volume":"2025","author":"Jiang","year":"2025","journal-title":"J. Food Biochem."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010143","article-title":"Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity","volume":"11","author":"Springer","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib38","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1007\/s12668-023-01288-7","article-title":"Polyphenol-loaded nano-carriers for breast cancer therapy: a comprehensive review","volume":"14","author":"Bhat","year":"2024","journal-title":"BioNanoScience"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib39","article-title":"Ultrafine resveratrol particles: supercritical antisolvent preparation and evaluation in vitro and in vivo","volume":"2015","author":"Wang","year":"2015","journal-title":"Adv. Mater. Sci. Eng."},{"issue":"11","key":"10.1016\/j.prp.2026.156588_bib40","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2174\/092986712799945085","article-title":"Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions","volume":"19","author":"R. Neves","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2011.09.083","article-title":"Administration of resveratrol: what formulation solutions to bioavailability limitations?","volume":"158","author":"Amri","year":"2012","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/pharmaceutics16040569","article-title":"Enhancing the bioavailability of resveratrol: combine it, derivatize it, or encapsulate it?","volume":"16","author":"Salla","year":"2024","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib43","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1166\/jbn.2010.1161","article-title":"Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats","volume":"6","author":"Frozza","year":"2010","journal-title":"J. Biomed. Nanotechnol."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/gerona\/glr062","article-title":"Challenges of translating basic research into therapeutics: resveratrol as an example","volume":"67","author":"Smoliga","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib45","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/acsptsci.4c00029","article-title":"Third-generation solid dispersion through lyophilization enhanced oral bioavailability of resveratrol","volume":"7","author":"Almeida","year":"2024","journal-title":"ACS Pharmacol. & Transl. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib46","article-title":"Advancements in Phytosomal Therapies for Liver Cancer: A Comprehensive Review","author":"Kothawade","year":"2024","journal-title":"Curr. Cancer Drug. Targets"},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib47","first-page":"9845","article-title":"Resveratrol suppresses human cervical carcinoma cell proliferation and elevates apoptosis via the mitochondrial and p53 signaling pathways","volume":"15","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015288","article-title":"Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells","volume":"5","author":"Chen","year":"2010","journal-title":"PloS. One"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12885-018-4504-5","article-title":"Resveratrol induces autophagy-dependent apoptosis in HL-60 cells","volume":"18","author":"Fan","year":"2018","journal-title":"BMC Cancer"},{"issue":"68","key":"10.1016\/j.prp.2026.156588_bib50","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.18632\/oncotarget.25993","article-title":"Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells","volume":"9","author":"Chung","year":"2018","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.prp.2026.156588_bib51","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.3390\/ijms22115969","article-title":"Resveratrol attenuates the proliferation of prostatic stromal cells in benign prostatic hyperplasia by regulating cell cycle progression, apoptosis, signaling pathways, BPH markers, and NF-\u03baB activity","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3892\/mmr.2014.2716","article-title":"Resveratrol inhibits the proliferation of human melanoma cells by inducing G1\/S cell cycle arrest and apoptosis","volume":"11","author":"Wu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib53","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3892\/mmr.2014.3100","article-title":"Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells","volume":"11","author":"Yuan","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13065-020-00667-5","article-title":"Finding an efficient tetramethylated hydroxydiethylene of resveratrol analogue for potential anticancer agent","volume":"14","author":"Xin","year":"2020","journal-title":"BMC Chem."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib55","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/jmf.2010.1126","article-title":"Resveratrol Arrests Cell Cycle and Induces Apoptosis in Human Hepatocellular Carcinoma Huh-7 Cells","volume":"13","author":"Liao","year":"2010","journal-title":"J. Med. Food"},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126322","article-title":"Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines","volume":"22","author":"Bostan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib57","article-title":"Screening of Natural Stilbene Oligomers from Vitis vinifera for Anticancer Activity on Human Hepatocellular Carcinoma Cells","volume":"9","author":"Aja","year":"2020","journal-title":"Antioxid. (Basel)"},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3892\/mmr.2022.12696","article-title":"Piceatannol suppresses inflammation and promotes apoptosis in rheumatoid arthritis-fibroblast-like synoviocytes by inhibiting the NF-\u03baB and MAPK signaling pathways","volume":"25","author":"Gao","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2026.156588_bib59","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.3390\/ani11123516","article-title":"Resveratrol relieved acute liver damage in ducks (Anas platyrhynchos) induced by AFB1 via modulation of apoptosis and Nrf2 signaling pathways","volume":"11","author":"Liu","year":"2021","journal-title":"Animals"},{"issue":"21","key":"10.1016\/j.prp.2026.156588_bib60","doi-asserted-by":"crossref","first-page":"12946","DOI":"10.3390\/ijms232112946","article-title":"Reprograming of gene expression of key inflammatory signaling pathways in human peripheral blood mononuclear cells by soybean lectin and resveratrol","volume":"23","author":"Qureshi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030652","article-title":"Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers","volume":"19","author":"Farooqi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"37","key":"10.1016\/j.prp.2026.156588_bib62","doi-asserted-by":"crossref","first-page":"26759","DOI":"10.1074\/jbc.M703229200","article-title":"Chronic Treatment with Resveratrol Induces Redox Stress- and Ataxia Telangiectasia-mutated (ATM)-dependent Senescence in p53-positive Cancer Cells","volume":"282","author":"Heiss","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2026.156588_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/srep37417","article-title":"Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells","volume":"6","author":"Kong","year":"2016","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.prp.2026.156588_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26164840","article-title":"Enhancement of Anticancer Potential of Pterostilbene Derivative by Chalcone Hybridization","volume":"26","author":"Tang","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.prp.2026.156588_bib65","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.32604\/or.2025.065222","article-title":"Polyphenols in Pancreatic Cancer Management: Exploring the Roles and Mechanisms of Resveratrol and Epigallocatechin","volume":"33","author":"de la Garza-Kalife","year":"2025","journal-title":"Oncol. Res."},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12032-025-02903-1","article-title":"Resveratrol in oral cancer: a systematic review of preclinical studies on its anticancer mechanisms and therapeutic potential","volume":"42","author":"Li","year":"2025","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/09540105.2023.2265686","article-title":"Anti-cancer perspectives of resveratrol: A comprehensive review","volume":"34","author":"Anwar","year":"2023","journal-title":"Food Agric. Immunol."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib68","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/00006676-200211000-00024","article-title":"Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells","volume":"25","author":"Ding","year":"2002","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.prp.2026.156588_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70829","article-title":"Curcumin and Resveratrol as Dual Modulators of the STAT 3 Pathway in Lung Cancer: A Comprehensive Review","volume":"13","author":"Zamanian","year":"2025","journal-title":"Food Sci. & Nutr."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib70","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s12672-025-03079-w","article-title":"A review of synergistic strategies in cancer therapy: resveratrol-loaded hydrogels for targeted and multimodal treatment","volume":"16","author":"Fu","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/pharmaceutics17010134","article-title":"Resveratrol\u2014A promising therapeutic agent with problematic properties","volume":"17","author":"Radeva","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib72","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/medicina61060981","article-title":"From Nature to Nanomedicine: Enhancing the Antitumor Efficacy of Rhein, Curcumin, and Resveratrol","volume":"61","author":"Trofin","year":"2025","journal-title":"Medicina"},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib73","article-title":"Unlocking the Potential of Nutraceuticals in Cancer Chemotherapy: A Comprehensive Review","volume":"17","author":"Aggarwal","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.prp.2026.156588_bib74","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fphar.2018.01534","article-title":"A review of resveratrol as a potent chemoprotective and synergistic agent in cancer chemotherapy","volume":"9","author":"Xiao","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12672-025-02471-w","article-title":"Modulation of the PI3K\/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity","volume":"16","author":"Hedayati","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib76","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12935-021-02179-1","article-title":"STAT3 pathway as a molecular target for resveratrol in breast cancer treatment","volume":"21","author":"Kohandel","year":"2021","journal-title":"Cancer Cell. Int."},{"issue":"77","key":"10.1016\/j.prp.2026.156588_bib77","article-title":"Unfolding the roles of resveratrol in p53 regulation","volume":"9","author":"de Queiroz","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2026.156588_bib78","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fimmu.2023.1225530","article-title":"Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment","volume":"14","author":"Brockmueller","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156588_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/590393","article-title":"Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation","volume":"2013","author":"Shen","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"49","key":"10.1016\/j.prp.2026.156588_bib80","doi-asserted-by":"crossref","first-page":"29112","DOI":"10.18632\/oncotarget.25631","article-title":"Resveratrol prevents p53 aggregation in vitro and in breast cancer cells","volume":"9","author":"Ferraz da Costa","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gde.2008.01.020","article-title":"NF-kappaB and cancer-identifying targets and mechanisms","volume":"18","author":"Naugler","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib82","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm (2020)"},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib83","first-page":"2949","article-title":"Resveratrol induces apoptosis in SGC-7901 gastric cancer cells","volume":"16","author":"Wu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12882-016-0233-7","article-title":"Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTP\u03b5 and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma","volume":"17","author":"Kim","year":"2016","journal-title":"BMC Nephrol."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib85","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbrc.2008.10.158","article-title":"Regulation of apoptosis by resveratrol through JAK\/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells","volume":"377","author":"Madan","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddiscovery.2015.61","article-title":"Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2\u2013Akt axis","volume":"1","author":"Vinod","year":"2015","journal-title":"Cell. death Discov."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib87","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3892\/ijo.2016.3559","article-title":"Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways","volume":"49","author":"Cao","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib88","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3390\/nu7064383","article-title":"Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K\/Akt\/NF-\u03baB Signaling Pathway","volume":"7","author":"Jiao","year":"2015","journal-title":"Nutrients"},{"issue":"33","key":"10.1016\/j.prp.2026.156588_bib89","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.2174\/09298673113209990251","article-title":"Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K\/Akt\/NF-\u03baB pathway","volume":"20","author":"Li","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prp.2026.156588_bib90","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fphar.2021.710304","article-title":"Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways","volume":"12","author":"Ch\u00e1irez-Ram\u00edrez","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib91","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10456-010-9187-8","article-title":"Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture","volume":"13","author":"Trapp","year":"2010","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib92","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3892\/mmr.2015.3675","article-title":"Anti-angiogenic effects of resveratrol in combination with 5-fluorouracil on B16 murine melanoma cells","volume":"12","author":"Lee","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib93","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/molecules21030304","article-title":"Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases","volume":"21","author":"Lan\u00e7on","year":"2016","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020191","article-title":"Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression","volume":"10","author":"Varghese","year":"2020","journal-title":"Biomolecules"},{"issue":"19_ement","key":"10.1016\/j.prp.2026.156588_bib95","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1538-7445.AM2014-1008","volume":"74","author":"Wong","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2026.156588_bib96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12885-015-1119-y","article-title":"Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-\u03b21\/Smads signaling pathway mediated Snail\/E-cadherin expression","volume":"15","author":"Ji","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib97","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3892\/mmr.2014.2417","article-title":"A novel anti\u2011cancer effect of resveratrol: reversal of epithelial\u2011mesenchymal transition in prostate cancer cells","volume":"10","author":"Li","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"33","key":"10.1016\/j.prp.2026.156588_bib98","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.2174\/09298673113209990251","article-title":"Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K\/Akt\/NF-\u03baB pathway","volume":"20","author":"Li","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prp.2026.156588_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.978625","article-title":"\u03b21-Integrin plays a major role in resveratrol-mediated anti-invasion effects in the CRC microenvironment","volume":"13","author":"Brockmueller","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156588_bib100","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8453011","article-title":"Resveratrol Induces Apoptosis, Suppresses Migration, and Invasion of Cervical Cancer Cells by Inhibiting the Hedgehog Signaling Pathway","volume":"2022","author":"Jiang","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"11","key":"10.1016\/j.prp.2026.156588_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078700","article-title":"Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt\/\u03b2-catenin signal pathway","volume":"8","author":"Ji","year":"2013","journal-title":"PloS. One"},{"key":"10.1016\/j.prp.2026.156588_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1321973","article-title":"Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling","volume":"2019","author":"Song","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26082204","article-title":"Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro","volume":"26","author":"Yang","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"cell"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib106","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell. death & Dis."},{"issue":"18","key":"10.1016\/j.prp.2026.156588_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184282","article-title":"Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets","volume":"25","author":"Talib","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061812","article-title":"Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights","volume":"19","author":"de S\u00e1 Coutinho","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26051343","article-title":"Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment","volume":"26","author":"Chhabra","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2026.156588_bib110","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fphar.2018.01255","article-title":"Is Resveratrol a Cancer Immunomodulatory Molecule?","volume":"9","author":"Trung","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156588_bib111","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6781872","article-title":"The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans","volume":"2017","author":"Espinoza","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib112","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2020.11809","article-title":"Resveratrol induces human colorectal cancer cell apoptosis by activating the mitochondrial pathway via increasing reactive oxygen species","volume":"23","author":"Fu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"42","key":"10.1016\/j.prp.2026.156588_bib113","doi-asserted-by":"crossref","first-page":"41482","DOI":"10.1074\/jbc.M304896200","article-title":"Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells","volume":"278","author":"Delmas","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib114","article-title":"Cytotoxic Activity of the Red Grape Polyphenol Resveratrol against Human Prostate Cancer Cells: A Molecular Mechanism Mediated by Mobilization of Nuclear Copper and Generation of Reactive Oxygen Species","volume":"14","author":"Farhan","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.prp.2026.156588_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1225530","article-title":"Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment","volume":"14","author":"Brockmueller","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156588_bib116","article-title":"Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156588_bib117","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12032-024-02405-6","article-title":"Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between \u03b2-catenin and GLI-1 through p53-independent activation of p21","volume":"41","author":"Bhal","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2026.156588_bib118","article-title":"Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy","volume":"17","author":"Keshavarzmotamed","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib119","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mito.2012.10.010","article-title":"Resveratrol depletes mitochondrial DNA and inhibition of autophagy enhances resveratrol-induced caspase activation","volume":"13","author":"Prabhu","year":"2013","journal-title":"Mitochondrion"},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib120","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1002\/ptr.8184","article-title":"Resveratrol triggers autophagy-related apoptosis to inhibit the progression of colorectal cancer via inhibition of FOXQ1","volume":"38","author":"Zhou","year":"2024","journal-title":"Phytother. Res."},{"issue":"22","key":"10.1016\/j.prp.2026.156588_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213689","article-title":"Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review","volume":"23","author":"Jang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib122","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/antiox12020407","article-title":"Melanoma cellular signaling transduction pathways targeted by polyphenols action mechanisms","volume":"12","author":"Isacescu","year":"2023","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.prp.2026.156588_bib123","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.18632\/oncotarget.15303","article-title":"Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53\/p21WAF1\/CIP1 and p27KIP1 pathway","volume":"8","author":"Singh","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib124","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3892\/ijo.2012.1325","article-title":"Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells","volume":"40","author":"Miki","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib125","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1021\/jf800175a","article-title":"Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells","volume":"56","author":"Juan","year":"2008","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib126","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.3892\/or.2016.4716","article-title":"Gold-conjugated resveratrol nanoparticles attenuate the invasion and MMP-9 and COX-2 expression in breast cancer cells","volume":"35","author":"Park","year":"2016","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib127","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mnfr.200700325","article-title":"Resveratrol inhibits migration and invasion of human breast-cancer cells","volume":"52","author":"Tang","year":"2008","journal-title":"Mol. Nutr. & Food Res."},{"key":"10.1016\/j.prp.2026.156588_bib128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2012.09.017","article-title":"Resveratrol inhibits TGF-\u03b21-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis","volume":"303","author":"Wang","year":"2013","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1535370218824538","article-title":"Evidence that TNF-\u03b2 induces proliferation in colorectal cancer cells and resveratrol can down-modulate it","volume":"244","author":"Buhrmann","year":"2019","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/1574892815666200910164641","article-title":"Phytochemicals as PI3K\/ Akt\/ mTOR Inhibitors and Their Role in Breast Cancer Treatment","volume":"15","author":"Narayanankutty","year":"2020","journal-title":"Recent. Pat. Anticancer. Drug. Discov."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cad.0000203387.29916.8e","article-title":"Bax and Bak are the critical complementary effectors of colorectal cancer cell apoptosis by chemopreventive resveratrol","volume":"17","author":"P\u00f6hland","year":"2006","journal-title":"Anticancer. Drugs"},{"issue":"17","key":"10.1016\/j.prp.2026.156588_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71194","article-title":"Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis","volume":"14","author":"de Sousa","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2026.156588_bib133","article-title":"Characteristics and Biomarkers of Ferroptosis","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"08","key":"10.1016\/j.prp.2026.156588_bib134","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1142\/S0192415X22500902","article-title":"Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol","volume":"50","author":"Yu","year":"2022","journal-title":"Am. J. Chin. Med."},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib135","first-page":"751","article-title":"Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment","volume":"17","author":"Zhang","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib136","doi-asserted-by":"crossref","DOI":"10.1186\/s12903-024-04395-3","article-title":"Effect and mechanism of resveratrol on ferroptosis mediated by p53\/SLC7A11 in oral squamous cell carcinoma","volume":"24","author":"Mao","year":"2024","journal-title":"BMC Oral. Health"},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020475","article-title":"Review and Chemoinformatic Analysis of Ferroptosis Modulators with a Focus on Natural Plant Products","volume":"28","author":"Stepani\u0107","year":"2023","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib138","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell. Biol."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib139","first-page":"3783","article-title":"Resveratrol induces p53 in colorectal cancer through SET7\/9","volume":"17","author":"Liu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"18","key":"10.1016\/j.prp.2026.156588_bib140","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.3390\/molecules26185586","article-title":"Comparative analysis of the antitumor activity of cis-and trans-resveratrol in human cancer cells with different p53 status","volume":"26","author":"Leischner","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib141","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxlet.2010.08.010","article-title":"Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation","volume":"199","author":"Zheng","year":"2010","journal-title":"Toxicol. Lett."},{"issue":"19","key":"10.1016\/j.prp.2026.156588_bib142","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.3390\/ijms221910883","article-title":"At a crossroads to cancer: how p53-induced cell fate decisions secure genome integrity","volume":"22","author":"Rizzotto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.prp.2026.156588_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1473939","article-title":"Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics","volume":"15","author":"Peng","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib145","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell. Death Differ."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib146","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"11-12","key":"10.1016\/j.prp.2026.156588_bib148","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70010","article-title":"Ferroptosis: mechanisms and therapeutic targets","volume":"5","author":"Zhou","year":"2024","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib150","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2026.156588_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron Metabolism in Ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.prp.2026.156588_bib152","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ijms24010449","article-title":"Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102365","article-title":"A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis","volume":"54","author":"Fuhrmann","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib154","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/16078454.2022.2132362","article-title":"From iron chelation to overload as a therapeutic strategy to induce ferroptosis in hematologic malignancies","volume":"27","author":"Li","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.prp.2026.156588_bib155","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v13i8.6801","article-title":"Unraveling the Dual Nature of GPx4: From Ferroptosis Regulation to Therapeutic Innovation in Human Pathologies","volume":"13","author":"Wu","year":"2025","journal-title":"Med. Res. Arch."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib156","article-title":"Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it?","volume":"2","author":"Conrad","year":"2015","journal-title":"Mol. Cell. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib157","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","article-title":"mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107583","article-title":"Ferroptosis regulation by Cap'n'collar family transcription factors","volume":"300","author":"Murray","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.prp.2026.156588_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/nu15092115","article-title":"Resveratrol Alleviates Diabetic Periodontitis-Induced Alveolar Osteocyte Ferroptosis Possibly via Regulation of SLC7A11\/GPX4","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2026.156588_bib160","article-title":"Ferroptosis: Biochemistry and Biology in Cancers","volume":"11","author":"Shi","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156588_bib161","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/febs.16382","article-title":"Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal","volume":"290","author":"Nishizawa","year":"2023","journal-title":"Febs J."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib162","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12903-024-04395-3","article-title":"Effect and mechanism of resveratrol on ferroptosis mediated by p53\/SLC7A11 in oral squamous cell carcinoma","volume":"24","author":"Mao","year":"2024","journal-title":"BMC Oral. Health"},{"key":"10.1016\/j.prp.2026.156588_bib163","article-title":"Oxyresveratrol as a novel ferroptosis inducer exhibits anticancer activity against breast cancer via the EGFR\/PI3K\/AKT\/GPX4 signalling axis","volume":"15","author":"Xiang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.prp.2026.156588_bib164","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jemt.24335","article-title":"Resveratrol inhibits ferroptosis via activating NRF2\/GPX4 pathway in mice with spinal cord injury","volume":"86","author":"Ni","year":"2023","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.prp.2026.156588_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115346","article-title":"Resveratrol improves the cytotoxic effect of CD8+ T cells in the tumor microenvironment by regulating HMMR\/Ferroptosis in lung squamous cell carcinoma","volume":"229","author":"Shan","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7998","key":"10.1016\/j.prp.2026.156588_bib166","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41586-023-06983-9","article-title":"7-Dehydrocholesterol dictates ferroptosis sensitivity","volume":"626","author":"Li","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib167","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41418-024-01270-0","article-title":"APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy","volume":"31","author":"Du","year":"2024","journal-title":"Cell. Death & Differ."},{"key":"10.1016\/j.prp.2026.156588_bib168","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/antiox13030334","article-title":"Beyond Mortality: Exploring the Influence of Plant Phenolics on Modulating Ferroptosis\u2014A Systematic Review","volume":"13","author":"\u017divanovi\u0107","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.prp.2026.156588_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1473939","article-title":"Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics","volume":"15","author":"Peng","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib170","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.7150\/jca.109350","article-title":"Resveratrol induces oxidative stress and downregulates GPX4 and xCT to activate the ferroptosis pathway for anti-bladder cancer organoids","volume":"16","author":"Chen","year":"2025","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib171","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/biom16010118","article-title":"Resveratrol for Cancer Treatment: Effects on Metabolism and Immune Cells","volume":"16","author":"Bao","year":"2026","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib172","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/ptr.7754","article-title":"Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects","volume":"37","author":"Shahcheraghi","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.prp.2026.156588_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107895","article-title":"Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells","volume":"98","author":"Mu","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.prp.2026.156588_bib174","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41419-022-05384-6","article-title":"Ferroptosis: a double-edged sword mediating immune tolerance of cancer","volume":"13","author":"Dang","year":"2022","journal-title":"Cell. death & Dis."},{"key":"10.1016\/j.prp.2026.156588_bib175","article-title":"Plant-Derived Phytochemicals and Their Nanoformulations for Inducing Programed Cell Death in Cancer","volume":"7","author":"Wang","year":"2024","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib176","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8782","article-title":"Natural products targeting ferroptosis pathways in cancer therapy (Review)","volume":"52","author":"Na","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156588_bib177","article-title":"Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review","volume":"23","author":"Amini","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"issue":"31","key":"10.1016\/j.prp.2026.156588_bib178","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.2174\/0929867331666230719124453","article-title":"Ferroptosis-induced Cardiotoxicity and Antitumor Drugs","volume":"31","author":"Beretta","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prp.2026.156588_bib179","article-title":"Ferroptosis in Cancer Treatment: Another Way to Rome","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156588_bib180","first-page":"2024","article-title":"Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib181","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/1878-0261.13649","article-title":"A guide to ferroptosis in cancer","volume":"18","author":"Yapici","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2026.156588_bib182","article-title":"A Promising Future of Ferroptosis in Tumor Therapy","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib183","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s10020-023-00730-6","article-title":"Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH\/GPX4 pathway","volume":"29","author":"Wang","year":"2023","journal-title":"Mol. Med."},{"issue":"20","key":"10.1016\/j.prp.2026.156588_bib184","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1111\/jcmm.17874","article-title":"Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1\/p53 pathway activation","volume":"27","author":"Zhang","year":"2023","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"10.1016\/j.prp.2026.156588_bib185","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10495-020-01642-0","article-title":"The interplay between apoptosis and ferroptosis mediated by ER stress","volume":"25","author":"Lee","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.prp.2026.156588_bib186","article-title":"Targeting the OXNAD1\u2013PTGS2 axis with resveratrol overcomes ferroptosis Inhibition and reverses 5-FU resistance in gastric cancer","author":"Wang","year":"2026","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib187","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.70153","article-title":"Concurrent Ferroptosis and Apoptosis in Resveratrol-Treated Glioblastoma Cells: Relevance With NRF2 Downregulation and Oxidative Stress","volume":"50","author":"Farman","year":"2026","journal-title":"Cell. Biol. Int."},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib188","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.7150\/jca.109350","article-title":"Resveratrol Induces Oxidative Stress and Downregulates GPX4 and xCT to Activate the Ferroptosis Pathway for Anti-Bladder Cancer Organoids","volume":"16","author":"Chen","year":"2025","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib189","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.taap.2006.12.025","article-title":"Resveratrol: a review of preclinical studies for human cancer prevention","volume":"224","author":"Athar","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib190","article-title":"Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions","volume":"12","author":"Kursvietiene","year":"2023","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.prp.2026.156588_bib191","article-title":"Resveratrol activates CD8(+) T cells through IL-18 bystander activation in lung adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib192","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12032-024-02333-5","article-title":"A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways","volume":"41","author":"Islam","year":"2024","journal-title":"Med. Oncol."},{"issue":"33","key":"10.1016\/j.prp.2026.156588_bib193","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.1080\/10408398.2022.2101428","article-title":"Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review","volume":"63","author":"Wu","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.prp.2026.156588_bib194","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.crfs.2020.10.004","article-title":"Resveratrol, cancer and cancer stem cells: A review on past to future","volume":"3","author":"Bhaskara","year":"2020","journal-title":"Curr. Res. Food Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020747","article-title":"Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities","volume":"25","author":"Brown","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib196","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/ijms25020747","article-title":"Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities","volume":"25","author":"Brown","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.prp.2026.156588_bib197","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1940-6207.CAPR-09-0155","article-title":"Resveratrol modulates drug-and carcinogen-metabolizing enzymes in a healthy volunteer study","volume":"3","author":"Chow","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.prp.2026.156588_bib198","first-page":"19","article-title":"Resveratrol for cancer prevention: current gaps and opportunities","author":"Brown","year":"2020","journal-title":"Natural products cancer chemoprevention single compounds combinations"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib199","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1123\/ijsnem.2013-0045","article-title":"Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure","volume":"24","author":"Goh","year":"2014","journal-title":"Int. J. Sport. Nutr. Exerc. Metab."},{"key":"10.1016\/j.prp.2026.156588_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2022.102819","article-title":"Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial","volume":"66","author":"Mahjabeen","year":"2022","journal-title":"Complement. Ther. Med."},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib201","first-page":"1595","article-title":"Resveratrol enhances exercise-induced cellular and functional adaptations of skeletal muscle in older men and women","volume":"72","author":"Alway","year":"2017","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"issue":"8","key":"10.1016\/j.prp.2026.156588_bib202","doi-asserted-by":"crossref","first-page":"H1111","DOI":"10.1152\/ajpheart.00168.2014","article-title":"Resveratrol modulates the angiogenic response to exercise training in skeletal muscles of aged men","volume":"307","author":"Gliemann","year":"2014","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.prp.2026.156588_bib203","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1940-6207.CAPR-11-0148","article-title":"Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases\u2014Safety, pharmacokinetics, and pharmacodynamics","volume":"4","author":"Howells","year":"2011","journal-title":"Cancer Prev. Res."},{"issue":"19","key":"10.1016\/j.prp.2026.156588_bib204","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1158\/0008-5472.CAN-10-2027","article-title":"Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients","volume":"70","author":"Patel","year":"2010","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.prp.2026.156588_bib205","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1158\/0008-5472.CAN-10-2364","article-title":"Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis","volume":"70","author":"Brown","year":"2010","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib206","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.12154","article-title":"A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma","volume":"160","author":"Popat","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"14","key":"10.1016\/j.prp.2026.156588_bib207","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/pros.23024","article-title":"A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination","volume":"75","author":"Paller","year":"2015","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib208","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/pros.23006","article-title":"Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men","volume":"75","author":"Kj\u00e6r","year":"2015","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib209","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/01635581.2012.654926","article-title":"Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer","volume":"64","author":"Zhu","year":"2012","journal-title":"Nutr. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib210","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2014.11.004","article-title":"Resveratrol and cancer: Challenges for clinical translation","volume":"1852","author":"Singh","year":"2015","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.prp.2026.156588_bib211","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fmolb.2021.649395","article-title":"Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer","volume":"8","author":"Sharifi-Rad","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.prp.2026.156588_bib212","article-title":"Lipid-Coated Nanocrystals as a Tool for Improving the Antioxidant Activity of Resveratrol","volume":"11","author":"Argenziano","year":"2022","journal-title":"Antioxid. (Basel)"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib213","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"npj Precis. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib214","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030933","article-title":"The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/nu8030145","article-title":"Sirt1 is required for resveratrol-mediated chemopreventive effects in colorectal cancer cells","volume":"8","author":"Buhrmann","year":"2016","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib216","doi-asserted-by":"crossref","first-page":"68","DOI":"10.30539\/ijvm.v44i1.939","article-title":"Cytotoxic effect of resveratrol on colorectal cancer cell line","volume":"44","author":"Khayoon","year":"2020","journal-title":"Iraqi J. Vet. Med."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib217","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1006\/bbrc.2002.6554","article-title":"Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo","volume":"291","author":"Bove","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib218","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1089\/152308601317203512","article-title":"Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells","volume":"3","author":"Serrero","year":"2001","journal-title":"Antioxid. Redox Signal."},{"issue":"5A","key":"10.1016\/j.prp.2026.156588_bib219","first-page":"4039","article-title":"Combined effects of resveratrol and paclitaxel on lung cancer cells","volume":"23","author":"Kubota","year":"2003","journal-title":"Anticancer. Res."},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2010.11.012","article-title":"Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling","volume":"301","author":"He","year":"2011","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib221","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijms18122589","article-title":"The role of resveratrol in cancer therapy","volume":"18","author":"Ko","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016530","article-title":"Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition","volume":"6","author":"Shankar","year":"2011","journal-title":"PloS. One"},{"issue":"20","key":"10.1016\/j.prp.2026.156588_bib223","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3748\/wjg.v10.i20.3048","article-title":"Effect of resveratrol and in combination with 5-FU on murine liver cancer","volume":"10","author":"Wu","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib224","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12906-017-1956-0","article-title":"Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells","volume":"17","author":"Jiang","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.prp.2026.156588_bib225","doi-asserted-by":"crossref","first-page":"01","DOI":"10.33140\/IJNN.10.01.03","article-title":"Lipid Nanocarriers for Targeted Repigmentation in Vitiligo: Advances in Melanocyte Modulation and Topical Delivery","volume":"10","author":"Parga","year":"2025","journal-title":"Int. J. Nanotechnol. Nanomed."},{"issue":"8_ement_2","key":"10.1016\/j.prp.2026.156588_bib226","article-title":"Abstract CT252: COLO-PREVENT: A platform for developing colorectal cancer prevention therapies","volume":"85","author":"Fan","year":"2025","journal-title":"Cancer Res."},{"issue":"8_ement_1","key":"10.1016\/j.prp.2026.156588_bib227","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1158\/1538-7445.AM2025-6345","article-title":"Abstract 6345: Establishing a preclinical cell model to assess the impact of metabolic status on the efficacy of preventive therapies: insights for the COLO-PREVENT trial","volume":"85","author":"Jarman","year":"2025","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib228","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2184.2011.00783.x","article-title":"Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro","volume":"44","author":"Al-Abd","year":"2011","journal-title":"Cell. Prolif."},{"issue":"4","key":"10.1016\/j.prp.2026.156588_bib229","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040925","article-title":"Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer","volume":"20","author":"Han","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156588_bib230","article-title":"Resveratrol-loaded nanomedicines for cancer applications","volume":"4","author":"Annaji","year":"2021","journal-title":"Cancer Rep."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib231","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.12160","article-title":"Resveratrol-based combinatorial strategies for cancer management","volume":"1290","author":"Singh","year":"2013","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib232","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fphar.2022.1068863","article-title":"Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: Focusing on oxidative stress, and cell cycle arrest","volume":"13","author":"Rahimifard","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.prp.2026.156588_bib233","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.3390\/ijms231810627","article-title":"Natural radiosensitizers in radiotherapy: Cancer treatment by combining ionizing radiation with resveratrol","volume":"23","author":"Komorowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156588_bib234","series-title":"Nutraceuticals and Cancer","first-page":"355","article-title":"Augmenting the efficacy of chemo-and radio-therapy by nutraceuticals: Evidence from pre-clinical and clinical trials","author":"Li","year":"2011"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-023-01800-3","article-title":"Co-inhibition of TIGIT and PD-1\/PD-L1 in cancer immunotherapy: mechanisms and clinical trials","volume":"22","author":"Chu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156588_bib236","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ptr.8082","article-title":"Phytochemicals in regulating PD-1\/PD-L1 and immune checkpoint blockade therapy","volume":"38","author":"Zhang","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.prp.2026.156588_bib237","article-title":"Human serum albumin-resveratrol complex formation: Effect of the phenolic chemical structure on the kinetic and thermodynamic parameters of the interactions","volume":"307","author":"de Paula Rezende","year":"2020","journal-title":"Food Chem."},{"key":"10.1016\/j.prp.2026.156588_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121086","article-title":"Efficacy of a resveratrol nanoformulation based on a commercially available liposomal platform","volume":"608","author":"Caddeo","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2026.156588_bib239","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.649395","article-title":"Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer","volume":"8","author":"Sharifi-Rad","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.prp.2026.156588_bib240","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/nu10121892","article-title":"Health effects of resveratrol: Results from human intervention trials","volume":"10","author":"Ram\u00edrez-Garza","year":"2018","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.prp.2026.156588_bib241","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","volume":"85","author":"Turner","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib242","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41120-022-00058-1","article-title":"Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL (TM)","volume":"8","author":"Kemper","year":"2022","journal-title":"AAPS Open."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2018.176","article-title":"Resveratrol: Twenty Years of Growth, Development and Controversy","volume":"27","author":"Pezzuto","year":"2019","journal-title":"Biomol. Ther. (Seoul. )"},{"key":"10.1016\/j.prp.2026.156588_bib244","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/CCID.S543849","article-title":"Resveratrol in Dermatological Therapy: A Critical Review of Mechanisms, Delivery Innovations, and Clinical Frontiers","author":"Cui","year":"2025","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2026.156588_bib245","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/etm.2015.2895","article-title":"Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers","volume":"11","author":"Sergides","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prp.2026.156588_bib246","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.exger.2014.05.015","article-title":"Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study","volume":"57","author":"Anton","year":"2014","journal-title":"Exp. Gerontol."},{"issue":"6","key":"10.1016\/j.prp.2026.156588_bib247","doi-asserted-by":"crossref","DOI":"10.3390\/nu8060353","article-title":"Challenges in Analyzing the Biological Effects of Resveratrol","volume":"8","author":"Erdogan","year":"2016","journal-title":"Nutrients"},{"issue":"34","key":"10.1016\/j.prp.2026.156588_bib248","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.2174\/13816128113199990407","article-title":"Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence","volume":"19","author":"Tom\u00e9-Carneiro","year":"2013","journal-title":"Curr. Pharm. Des."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:28:34Z","timestamp":1786501714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826002414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":248,"alternative-id":["S0344033826002414"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156588","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ferroptosis with resveratrol: Advances in mechanistic understanding and cancer therapy applications","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156588"}}